SL PHARM announced that director and board secretary Liang Shujie holds 1.5008 million shares, accounting for 0.1461%; plans to reduce holdings by no more than 375,200 shares, accounting for 0.0365%, through centralized bidding within three months after the announcement date, with no reduction during the window period, and the reduction price will be determined at market price
